Search results
Results From The WOW.Com Content Network
1957–1958 influenza pandemic ('Asian flu') 1957–1958 Worldwide Influenza A virus subtype H2N2: 1–4 million [187] [203] [204] 1960–1962 Ethiopia yellow fever epidemic 1960–1962 Ethiopia: Yellow fever: 30,000 [205] Seventh cholera pandemic: 1961–present Worldwide Cholera (El Tor strain) 36,000 [citation needed] [206] Hong Kong flu ...
Canadian health officials reported that swine flu is hospitalizing three to four times as many children as regular seasonal flu. [350] On 30 May, New Zealand had 9 confirmed cases and 10 probables. During June cases in New Zealand rose rapidly. On 14 June the Ministry of Health announced a 65% increase in cases in just 24 hours.
The virus is a novel strain of the influenza virus, [2] for which existing vaccines against seasonal flu provided no protection. A study at the U.S. Centers for Disease Control and Prevention (CDC) published in May 2009 found that children had no preexisting immunity to the new strain but that adults, particularly those over 60, had some degree of immunity.
Concerns about and research of avian influenza (bird flu) H5N1 rise as increasing spillovers to and between mammals are reported, [needs update] [262] with the incoming WHO chief scientist warning governments should invest in H5N1 vaccines for all flu strains, [263] and prepare for a potential outbreak among humans (pandemic preparedness), [255 ...
As of September 2021, Spain is one of the countries with the highest percentage of its population vaccinated (76% fully vaccinated and 79% with the first dose), [30] while also being one of the countries more in favor of vaccines against COVID-19 (nearly 94% of its population is already vaccinated or wants to be). [31]
The COVID-19 pandemic in Spain has resulted in 13,980,340 [1] confirmed cases of COVID-19 and 121,852 [1] deaths.. The virus was first confirmed to have spread to Spain on 31 January 2020, when a German tourist tested positive for SARS-CoV-2 in La Gomera, Canary Islands. [2]
In 2020, the first COVID‑19 vaccines were developed and made available to the public through emergency authorizations [210] and conditional approvals. [211] [212] However, immunity from the vaccines was found to wane over time, requiring people to get booster doses of the vaccine to maintain protection against COVID‑19. [210]
The COVID-19 vaccines are widely credited for their role in reducing the severity and death caused by COVID-19. [128] [129] As of March 2023, more than 5.5 billion people had received one or more doses [130] (11.8 billion in total) in over 197 countries. The Oxford-AstraZeneca vaccine was the most widely used. [131]